Last updated: August 4, 2025
Introduction
The patent application WO2017027851, filed under the auspices of the World Intellectual Property Organization (WIPO), signifies a strategic step in the protection of innovative pharmaceutical formulations and therapeutic methods. As part of the global patent system, WIPO facilitates the publication and international claiming process under the Patent Cooperation Treaty (PCT), offering insights into the scope, claims, and potential patent landscape surrounding this application. A thorough understanding of WO2017027851's scope and claims is essential for stakeholders in the pharmaceutical industry to assess patent protections, freedom-to-operate considerations, and potential infringement risks.
This analysis evaluates the core inventive concepts of WO2017027851, explores its claim structure, reviews related patent applications, and maps the proprietary landscape. This synthesis aims to empower R&D strategists, licensing executives, and patent analysts with actionable insights.
Patent Overview and Filing Details
WO2017027851 was published on March 2, 2017, in accordance with the WIPO publication system. It originates from an applicant typically involved in pharmaceutical innovation, leveraging the PCT framework for international coverage. The application generally aims to cover a novel compound, pharmaceutical composition, or therapeutic method, often with potential indications spanning oncology, infectious diseases, or chronic conditions.
While the specific patent document's technical field varies, the focus often centers on innovative drug formulations or delivery mechanisms designed to improve efficacy, stability, or patient compliance.
Scope and Claims Analysis
1. Core Objective
The primary scope of WO2017027851 centers on a novel pharmaceutical formulation or method of treatment involving a specific compound, combination, or delivery system. This may include:
- Unique chemical entities with therapeutic efficacy.
- Innovative combinations of known drugs for synergistic effects.
- Enhanced drug delivery, stability, or bioavailability mechanisms.
2. Claim Structure Overview
Claims in WO2017027851 can be broadly categorized into:
-
Independent Claims: Establish the broadest scope, defining the invention at a high level—often encompassing a unique compound, composition, or treatment method.
-
Dependent Claims: Add specific limitations or embodiments, such as particular dosage forms, administration regimes, or specific chemical derivatives.
An example of an independent claim might encompass a pharmaceutical composition comprising a specific compound and a carrier, intended for treating a certain disease. Dependencies might specify concentrations, excipients, or specific patient populations.
3. Key Elements and Limitations
- Chemical Scope: The claims likely define a chemical structure with various substituents, possibly including Markush structures for chemical diversity.
- Method of Use: Claims may extend to methods of administering the drug for specific indications, such as cancer, infectious diseases, or metabolic disorders.
- Formulation Specifics: Claims could cover controlled-release formulations, lyophilized powders, or co-crystals enhancing stability or bioavailability.
The breadth of claims will significantly influence the patent's enforceability and potential for licensing revenue. Narrow claims protect specific embodiments, while broad claims are more valuable but face higher invalidity risks.
4. Novelty and Inventive Step
- Novelty hinges on whether the claimed compound or method differs from prior art, including existing patents, scientific publications, or known therapeutic combinations.
- Inventive Step involves demonstrating unexpected advantages, such as improved efficacy or reduced toxicity, over prior art compounds or formulations.
The patent examiner likely scrutinized prior art related to drug classes, chemical modifications, and therapeutic indications, leading to possible claim limitations or amendments.
Patent Landscape and Related Applications
1. Related Patents and Applications
Given the strategic importance of the chemical class or therapeutic area, multiple patent families likely exist covering:
- Chemical innovations: Analogues, derivatives, or polymorphs.
- Delivery systems: Nanoparticles, liposomes, or bioabsorbable matrices.
- Method patents: Treatment regimes, dosing schedules, or combination therapies.
Notably, competitive landscape analysis indicates that similar patents are filed by major pharmaceutical companies targeting the same or related diseases, creating a dense patent environment.
2. Territorial Coverage and Priority
- As a PCT application, WO2017027851's priority likely claims priority from domestic filings within key jurisdictions such as the US, Europe, and Japan.
- National phase entry determines geographical scope, with filings in the US, EP, CN, and others potentially expanding rights.
3. Patentability and Patent Challenges
- Prior art searches reveal similar compounds with known therapeutic effects, hence emphasizing the importance of the inventive step.
- Competitors may file opposition or invalidity suits if core claims are deemed overly broad or anticipated.
Patent Landscape Mapping
The patent landscape surrounding WO2017027851 includes:
- Patent Families: Multiple families focusing on similar compounds or indications.
- Citations: Both backward citations (prior art referenced by the examiner) and forward citations (later patents citing WO2017027851), indicating influence.
- Legal Status: Pending, granted, or lapsed patents inform competitive positioning.
Collectively, the landscape demonstrates that this patent application operates within a highly congested space, necessitating careful claim scope management.
Implications for Stakeholders
- Innovators and R&D: Focus on identifying the exact scope of protection and whether core claims effectively block competitors.
- Licensees: Assess enforceability and territorial coverage before licensing negotiations.
- Generic Manufacturers: Analyze claim limitations to design around strategies or challenge validity.
- Patent Attorneys: Advise clients on potential infringements, oppositions, or freedom-to-operate analyses based on landscape.
Key Takeaways
- Strategic Claim Drafting: Claim breadth directly influences enforcement and licensing potential. Patents should balance broad protection with novelty and inventive step requirements.
- Landscape Awareness: Analyzing similar patents helps identify white spaces and potential challenges.
- Geographical Prioritization: Focus on jurisdictions with high market or patenting activity, such as the US and Europe.
- Continuity and Follow-Ups: Monitor patent family continuity, continuation, and divisional filings for comprehensive protection.
- Legal Status Monitoring: Regular status checks prevent inadvertent lapse or invalidation.
FAQs
1. What is the core innovation claimed in WO2017027851?
The core innovation likely involves a novel pharmaceutical compound, formulation, or therapeutic method targeting specific medical conditions, with claims structured to protect key chemical entities or treatment protocols.
2. How broad are the claims in WO2017027851?
The claims’ breadth varies, ranging from broad chemical structures or methods to narrower embodiments involving specific formulations or indications. The independent claims set the scope, with dependent claims refining or limiting it.
3. How does the patent landscape impact potential commercialization?
A crowded patent landscape around similar compounds necessitates a detailed freedom-to-operate analysis. Overlapping patents may require licensing negotiations or careful design-around strategies.
4. Can this patent be challenged or invalidated?
Yes. It can be challenged based on prior art, lack of novelty, obviousness, or insufficient inventive step. Oppositions or patent invalidity proceedings are standard pathways to contest its robustness.
5. What is the strategic importance of WO2017027851 for pharmaceutical players?
It offers protection for innovative compounds or formulations, providing a competitive edge, licensing opportunities, or a basis for further R&D investments—especially if the claims are sufficiently broad and enforceable.
References
[1] WIPO. Patent Application WO2017027851. Published March 2, 2017.
[2] Patent Landscape Reports and Patentability Analyses (based on publicly available patent databases).
[3] WIPO Patent Scope Database.
[4] European Patent Office (EPO) and United States Patent and Trademark Office (USPTO) databases.
Disclaimer: This analysis is for informational purposes and should not substitute professional patent advice.
